Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2002European Journal Of Haematology

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti‐CD20 monoclonal antibody rituximab: a pilot study

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAristoteles GiagounidisMarien Hospital DüsseldorfJAJürgen AnhufPraxis für Hämatologie und OnkologiePSPhilipp SchneiderUniversity of Bern

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Giagounidis et al. (2002) studied this question.

synapsesocial.com/papers/69ffa2eab124fe5819858b22https://doi.org/10.1034/j.1600-0609.2002.02686.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma1997 · 1,713 citations
  2. 2A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients1994 · 56 citations
  3. 3Morbidity and mortality in adults with idiopathic thrombocytopenic purpura2001 · 496 citations
  4. 4Re‐evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases1990 · 147 citations
  5. 5A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma1992 · 92 citations